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January 2019 news items
Research Development Administrator Named
Contact: Diana Berkshire-Hearit
Jan. 7, 2019
Vice President Terri Goss Kinzy is pleased to announce that effective January 7, 2019 Kay
Mortellaro will assume the newly created position of Research Development Administrator in
the Office of the Vice President for Research (OVPR). In this role, Kay will focus on developing
programing and opportunities to grow our research awards and expenditures. She will expand
our ability to target and disseminate research funding opportunities, oversee limited
competitions, develop a library of proposal resources, oversee programing to prepare WMU
faculty and staff for the many different funding sources available, work collaboratively with the
colleges and the Office of Development and Alumni Relations and assist in the development of
major and interdisciplinary proposals for external funding.
Kay has extensive experience working on grant submission as a research program officer in
OVPR. Prior to that, she spent six years as the budget analyst for the College of Engineering and
Applied Sciences and served as the center coordinator for both the Transportation Research
Center for Livable Communities and The Georgeau Institute.

Changes to NIH Academic Research
Enhancement—AREA/R15 Program
On December 3, 2018, the National Institute of Health released a guide notice announcing changes to the
NIH Academic Research Enhancement—AREA Program. This document is intended to summarize those
changes to assist WMU Principal Investigators in preparing R15 applications. There remain some
questions that OVPR is continuing to research. This posting will be updated as more information becomes
available from NIH.
The current Parent Announcement, PA-18-504 expired January 7, 2019 and will not be reissued.


Going forward, the R15 activity code will include two programs:

1. Academic Research Enhancement Award—AREA for Undergraduate-Focused Institutions
2. Research Enhancement Award Program—REAP for Health Professional Schools and Graduate
Schools


Currently, there are 4 Funding Opportunity Announcements—FOAs active for the R15 mechanism.
Two for Undergraduate-focused institutions (these are the FOAs for most faculty at WMU to apply to)
and two for Health Professional Schools and Graduate Schools (this would apply to faculty at WMed).

1. PAR-18-714 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 –
Clinical Trial Not Allowed)
2. PAR-19-133 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
3.

PAR-19-134 Research Enhancement Award Program—REAP for Health Professional Schools and
Graduate Schools (R15 Clinical Trial Not Allowed)

4. PAR-19-135 Research Enhancement Award Program—REAP for Health Professional Schools and
Graduate Schools (R15 Clinical Trial Required)


Not all institutes and centers—ICs that participated in the previous AREA Parent Announcement
participate in the current FOAs Please check the FOA and any future FOAs carefully as participating
ICs may change.
Summary of changes under the AREA for Undergraduate-Focused Institutions (PAR-18-714 and PAF19-133)



New eligibility criteria. Under these two new FOAs, eligibility criteria include the following:

1. Only non-health professional schools and colleges are eligible under this FOA (note: we are currently
seeking clarification from NIH as to whether this applies to individual departments/schools within an
institution that issue health professional degrees such as a BSN).
2. All non-health professional components of the institution together have not received support from the
NIH totaling more than $6 million per year in 4 of the last 7 years. (Note: WMU currently qualifies
under this stipulation)
3. The qualifying academic component within an institution has greater undergraduate student
enrollment than graduate student enrollment.



The new AREA for Undergraduate-Focused Institutions, as the name implies, is designed to expose
undergraduates to research. The language below from the FOA excerpted below helps clarify what this
means:

1. The three objectives of this FOA are:
♦ Provide support for meritorious research at undergraduate-focused institutions or institutional
components;
♦ Strengthen the research environment at these institutions/components; and
♦ Give undergraduate students an opportunity to gain significant biomedical research experience
through active involvement in the research.
2. The research project must involve undergraduate students and the research team must be composed
primarily of undergraduate students.
3. An AREA application submitted to this FOA may include other investigators, such as technicians,
collaborators or consultants, or other individuals such as high school students, post baccalaureate
participants, graduate students, or postdoctoral fellows. However, involvement of such individuals
does not fulfill the goal to expose undergraduate students in eligible environments to research.


New information is now requested in the proposal documents. The list below highlights new
information that was not requested under the previous AREA Parent Announcement and is not a
complete list of what must be included in any particular document under the new FOA.

1. The Facilities and Other Resources document must now include:
♦ Description of plans to recruit well-qualified undergraduate students from diverse backgrounds to
participate in the research project.
♦ Description of the likely impact of the AREA grant on the ability of undergraduate students at the
institution to gain experience conducting biomedical research.
2. The Research Strategy document must now include:
♦ Describe how the proposed plan can achieve the specific aims using a research team composed
primarily of undergraduate students.
♦ Describe how undergraduate students will be exposed to and supervised in conducting hands-on,
rigorous research.
3. Letters of Support
♦ A letter signed by an institutional official certifying that WMU meets eligibility requirements.
Please note, OVPR will handle drafting and signing this letter.



The review criteria have also been modified to reflect the different goals of this FOA. The excerpts
below highlight some of the new language in the review criteria. Please review the FOA carefully for
the complete review criteria.

1. Significance
♦ If funded, will the AREA grant have a substantial effect on the applicant institution in terms of
strengthening the research environment and exposing undergraduate students to research?
2. Approach
♦ Is the project appropriate for execution primarily by undergraduates? Have the investigators
described appropriate plans for how undergraduates will be included as an integral part of the research
project?
♦ Does the application provide sufficient evidence that the project will likely stimulate the interests of
students so that they can consider a career in the biomedical sciences?
♦ Are appropriate plans in place to recruit a diverse and inclusive team of undergraduate researchers.
3. Environment

♦ Does the application demonstrate the likely availability of well-qualified students to
participate in the research project?
♦ Does the application demonstrate appropriate plans to recruit well-qualified undergraduate
students from diverse backgrounds to participate in the research project?
As always, please reach out to your Research Officer with any questions.

Common Rule Changes effective Jan. 21, 2019
Regulations governing human subjects research are changing. The federal Office for Human
Research Protections (OHRP) has announced changes to federal regulations that protect the
rights and welfare of human research participants. These regulatory changes to 45 CFR 46,
referred to as the “Revised Common Rule,” have been delayed twice and are scheduled to be
implemented on January 21, 2019. The Common Rule changes seek to modernize, strengthen
and make more effective the federal policies for the protection of human research participants.

WHAT THIS MEANS TO WMU RESEARCHERS:
All research projects that involve human subject must be submitted to the WMU IRB for review
and receive approval prior to implementation (e.g., recruitment, data collection, etc. cannot

proceed without IRB approval). The IRB will make the determination on the category of review,
continuing review, and post approval changes.
The WMU IRB and Research Compliance have been updating and revising policies and
procedures in preparation for the Revised Common Rule.
This guidance will take you through an overview of significant changes made to each section the
Common Rule. New guidance will be posted to the website as it becomes available.

Revised Common Rule Impact on Studies with Pending Approval on January 21, 2019
The most notable changes are to the consent process and form, what qualifies for exempt review,
and when continuing review is required. Due to the effective date and the implementation date
of the Revised Common Rule being the same, some studies awaiting approval may need to be
updated and resubmitted for review. Your study approval date or pending approval will
determine whether you must comply with the Revised Common Rule changes or will continue to
follow the Pre-2018 Common Rule.
Approved Before January 21, 2019
If your study was approved before January 21, 2019, the Pre-2018 Common Rule regulations will continue
to apply to your study.
Approved On or After January 21, 2019
Approval Date on or after January 21, 2019, you must adhere to the New Revised Common Rule.

1. Exempt or Expedited studies which are approved with modifications (revisions required), must satisfy
all conditions before January 21, 2019 or must comply with the Revised Common Rule.
2. A Full-Board Study which is approved with conditions (revisions required), will have an approval
date based on the date of the Full-Board Meeting when it was originally approved.
3. Important Note:
The Pre 2018 Common Rule will still apply to studies sponsored by federal agencies that have not yet
signed on to the Revised Common Rule (e.g., The Department of Justice (DOJ)).

Revised Common Rule Impact on Existing Studies
There may be some circumstances under which studies that must comply with the Pre 2018
Common Rule may switch to comply with the Revised Common Rule. The Office of the Vice
President for Research continues to work with the WMU IRB on this process. Guidance on
existing studies will be posted in the future.

Studies that must comply with the Revised Common Rule
“New” protocols (e.g., exempt, expedited, etc.) that are approved after the Revised Common
Rule goes into effect on January 21, 2019 must comply with the New Revised Common Rule.
Some change will reduce researchers’ burden and other requirements will increase research
responsibilities.
Consent Form—Informational Element
New Requirement—The consent form must begin with a concise summary of essential study
information that individuals would want to know in order to make an informed decision about
participation.
New Requirement—Consent form must disclose any plans to conduct future research using info
and/or biospecimens collected during the research.
New Requirement—If applicable, consent form must disclose whether: (a) subjects will share in
commercial profit; (b) clinically relevant research results will be returned; and (c) research will
or might include whole genome sequencing.

Exempt Categories Updated
New revised exempt categories and updated categories.
New Option—With safeguards in place, studies using benign behavioral interventions may
qualify for Exempt Review.
New Option—With a "Limited IRB Review" of a protocol plan to safeguard subjects’ privacy
and confidentiality, more studies will qualify for exempt review.

Continuing Review Requirement Changes
Continuing IRB review may no longer be required for many minimal risks studies. To assist
researchers approval letters will indicate what type of continuing review is required. The IRB
will continue to send notification at 60 and 30 days for the continuing review or progress report.

The IRB is still required to conduct post approval monitoring and an annual Progress Report and
Final Report will be required.

Post Approval Changes/Amendments/Modification
Amendments and modifications will still need to be submitted, reviewed, and approved by the
IRB prior to their implementation. In addition, unanticipated problems, protocol deviations, and
other Reportable Events will still need to be submitted to the IRB.
Post-approval monitoring will continue to ensure that study activities are carrying on as
described in the protocol.
The following studies will still need to undergo continuing review:


Research which requires annual review by a fully convened Board



Research which is subject to the US Food and Drug Administration (FDA) oversight or by another
sponsor that requires continuing review (e.g., Department of Justice, Department of Veterans Affairs,
etc.)



Research that was approved prior to the implementation date of January 21, 2019 and has not
transitioned to the revised Common Rule



Research subject to the discretion of the Human Subject Protection Program or WMU IRB that may
involve the following:

o Student-led research;
o Research involving non-WMU investigators;
o Research conducted internationally;
o Research including particularly vulnerable populations;
o Research involving additional regulatory oversight, such as a conflict of interest (COI)
management plan;
o Research amendment or incident report revealing new findings that require additional
oversight;
o Investigator that has had previous protocol deviations.

o Investigator that has had previous serious non-compliance or a pattern of non-serious noncompliance;
Revised Common Rule Weblink

Spring Convocation 2019
Contact: Diana Hearit
Jan. 24, 2019
KALAMAZOO, Mich.—Western Michigan University Spring Convocation on March 26, 2019

This event is organized by The Office of Vice President for Research to recognize the work of
WMU faculty.

FETZER CENTER
9 to 11:30 a.m.
Discovery Symposia
Discovery Symposium on Education, Room 2016/2018
Session Chairs: Selena Protacio and Charles Henderson
Discovery Symposium on Sustainability, Room 2020
Session Chairs: Xiaoyun Shao and Maarten Vanhof

Fulbright Workshop, Room 1040/1050
11:30 to 12:30 p.m.
Faculty Research and Creative Activity Awards Poster Presentations, Lobby
12:30 to 2 p.m.
Discovery Excellence Recognition Luncheon, Invited guests of the Vice President for Research
Keynote speaker: Susan Pozo, 2018 Distinguished Faculty Scholar
Downloadable copy

